Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):1-3. doi: 10.1158/1078-0432.ccr-1218-3.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myeloid, Chronic-Phase / drug therapy*
  • Leukemia, Myeloid, Chronic-Phase / mortality*
  • Piperazines / therapeutic use*
  • Prognosis
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / therapeutic use*
  • Survival Rate

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases